HCPCS Level II

HCPCS Level II 2014 code changes

Every HCPCS Level II code whose CMS add date or termination date falls in 2014, grouped by effective date. Each code's own page carries its full record.

280

Added

Deleted

For HCPCS Level II, MedCoder records each code's CMS add date and termination date from the alpha-numeric file. A deletion is listed on the first day the code is no longer valid (the day after its CMS termination date). Description revisions between quarterly files are not recorded as changes.

Added effective January 1, 2014 (248)

A4555 — Electrode/transducer for use with electrical stimulation device used for cancer treatment, replacement only
A7047 — Oral interface used with respiratory suction pump, each
A9520 — Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries
A9575 — Injection, gadoterate meglumine, 0.1 ml
A9599 — Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified
C5271 — Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
C5272 — Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
C5273 — Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
C5274 — Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
C5275 — Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
C5276 — Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
C5277 — Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
C5278 — Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
C9133 — Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
C9441 — Injection, ferric carboxymaltose, 1 mg
C9497 — Loxapine, inhalation powder, 10 mg
C9737 — Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)
E0766 — Electrical stimulation device used for cancer treatment, includes all accessories, any type
E1352 — Oxygen accessory, flow regulator capable of positive inspiratory pressure
G0461 — Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain
G0462 — Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)
G0463 — Hospital outpatient clinic visit for assessment and management of a patient
G9188 — Beta-blocker therapy not prescribed, reason not given
G9189 — Beta-blocker therapy prescribed or currently being taken
G9190 — Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)
G9191 — Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)
G9192 — Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)
G9193 — Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression
G9194 — Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase
G9195 — Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase
G9196 — Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))
G9197 — Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis
G9198 — Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given
G9199 — Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))
G9200 — Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given
G9201 — Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission
G9202 — Patients with a positive hepatitis c antibody test
G9203 — Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
G9204 — Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
G9205 — Patient starting antiviral treatmentfor hepatitis c during the measurement period
G9206 — Patient starting antiviral treatment for hepatitis c during the measurement period
G9207 — Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
G9208 — Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
G9209 — Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
G9210 — Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)
G9211 — Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given
G9212 — Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
G9213 — Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
G9214 — Cd4+ cell count or cd4+ cell percentage results documented
G9215 — Cd4+ cell count or percentage not documented as performed, reason not given
G9216 — Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given
G9217 — Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given
G9218 — Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given
G9219 — Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)
G9220 — Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)
G9221 — Pneumocystis jiroveci pneumonia prophlaxis prescribed
G9222 — Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3
G9223 — Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%
G9224 — Documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)
G9225 — Foot exam was not performed, reason not given
G9226 — Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed)
G9227 — Functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan at the time of the encounter
G9228 — Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)
G9229 — Chlamydia, gonorrhea, and syphilis screening results not documented (patient refusal is the only allowed exception)
G9230 — Chlamydia, gonorrhea, and syphilis not screened, reason not given
G9231 — Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period
G9232 — Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason (e.g., patient is unable to communicate the diagnosis of a comorbid condition; the patient is unwilling to communicate the diagnosis of a comorbid condition; or the patient is unaware of the comorbid condition, or any other specified patient reason)
G9233 — All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient
G9234 — I intend to report the total knee replacement measures group
G9235 — All quality actions for the applicable measures in the general surgery measures group have been performed for this patient
G9236 — All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient
G9237 — I intend to report the general surgery measures group
G9238 — I intend to report the optimizing patient exposure to ionizing radiation measures group
G9239 — Documentation of reasons for patient initiating maintenance hemodialysis with a catheter as the mode of vascular access (e.g., patient has a maturing arteriovenous fistula (avf)/arteriovenous graft (avg), time-limited trial of hemodialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons)
G9240 — Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated
G9241 — Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated
G9242 — Documentation of viral load equal to or greater than 200 copies/ml or viral load not performed
G9243 — Documentation of viral load less than 200 copies/ml
G9244 — Antiretroviral thereapy not prescribed
G9245 — Antiretroviral therapy prescribed
G9246 — Patient did not have two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart
G9247 — Patient had two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart
G9248 — Patient did not have a medical visit in the last 6 months
G9249 — Patient had a medical visit in the last 6 months
G9250 — Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment
G9251 — Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment
G9252 — Adenoma(s) or other neoplasm detected during screening colonoscopy
G9253 — Adenoma(s) or other neoplasm not detected during screening colonoscopy
G9254 — Documentation of patient discharged to home later than post-operative day 2 following cea or cas
G9255 — Documentation of patient discharged to home no later than post operative day 2 following cea or cas
G9256 — Documentation of patient death following cas
G9257 — Documentation of patient stroke following cas
G9258 — Documentation of patient stroke following cea
G9259 — Documentation of patient survival and absence of stroke following cas
G9260 — Documentation of patient death following cea
G9261 — Documentation of patient survival and absence of stroke following cea
G9262 — Documentation of patient death in the hospital following endovascular aaa repair
G9263 — Documentation of patient discharged alive following endovascular aaa repair
G9264 — Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (e.g., other medical reasons, patient declined arteriovenous fistula (avf)/arteriovenous graft (avg), other patient reasons)
G9265 — Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access
G9266 — Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access
G9267 — Documentation of patient with one or more complications or mortality within 30 days
G9268 — Documentation of patient with one or more complications within 90 days
G9269 — Documentation of patient without one or more complications and without mortality within 30 days
G9270 — Documentation of patient without one or more complications within 90 days
G9271 — Ldl value < 100
G9272 — Ldl value >= 100
G9273 — Blood pressure has a systolic value of < 140 and a diastolic value of < 90
G9274 — Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90
G9275 — Documentation that patient is a current non-tobacco user
G9276 — Documentation that patient is a current tobacco user
G9277 — Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux)
G9278 — Documentation that the patient is not on daily aspirin or anti-platelet regimen
G9279 — Pneumococcal screening performed and documentation of vaccination received prior to discharge
G9280 — Pneumococcal vaccination not administered prior to discharge, reason not specified
G9281 — Screening performed and documentation that vaccination not indicated/patient refusal
G9282 — Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons)
G9283 — Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9284 — Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9285 — Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer
G9286 — Antibiotic regimen prescribed within 10 days after onset of symptoms
G9287 — Antibiotic regimen not prescribed within 10 days after onset of symptoms
G9288 — Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)
G9289 — Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9290 — Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9291 — Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos
G9292 — Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)
G9293 — Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
G9294 — Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
G9295 — Specimen site other than anatomic cutaneous location
G9296 — Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure
G9297 — Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given
G9298 — Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)
G9299 — Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)
G9300 — Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)
G9301 — Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet
G9302 — Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given
G9303 — Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given
G9304 — Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant
G9305 — Intervention for presence of leak of endoluminal contents through an anastomosis not required
G9306 — Intervention for presence of leak of endoluminal contents through an anastomosis required
G9307 — No return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure
G9308 — Unplanned return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure
G9309 — No unplanned hospital readmission within 30 days of principal procedure
G9310 — Unplanned hospital readmission within 30 days of principal procedure
G9311 — No surgical site infection
G9312 — Surgical site infection
G9313 — Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason
G9314 — Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given
G9315 — Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis
G9316 — Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family
G9317 — Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed
G9318 — Imaging study named according to standardized nomenclature
G9319 — Imaging study not named according to standardized nomenclature, reason not given
G9320 — Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9321 — Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies documented in the 12-month period prior to the current study
G9322 — Count of previous ct and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies not documented in the 12-month period prior to the current study, reason not given
G9323 — Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9324 — All necessary data elements not included, reason not given
G9325 — Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9326 — Ct studies performed not reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements, reason not given
G9327 — Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements
G9328 — Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9329 — Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not given
G9340 — Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study
G9341 — Search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed
G9342 — Search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive, reason not given
G9343 — Due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9344 — Due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., non-affiliated external healthcare facilities or entities does not have archival abilities through a shared archival system)
G9345 — Follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors
G9346 — Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9347 — Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given
G9348 — Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons
G9349 — Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis
G9350 — Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis
G9351 — More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis
G9352 — More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given
G9353 — More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)
G9354 — One ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis
G9355 — Elective delivery (without medical indication) by cesarean birth or induction of labor not performed (<39 weeks of gestation)
G9356 — Elective delivery (without medical indication) by cesarean birth or induction of labor performed (<39 weeks of gestation)
G9357 — Post-partum screenings, evaluations and education performed
G9358 — Post-partum screenings, evaluations and education not performed
G9359 — Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier
G9360 — No documentation of negative or managed positive tb screen
G9361 — Medical indication for delivery by cesarean birth or induction of labor (<39 weeks of gestation) [documentation of reason(s) for elective delivery (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes (premature or prolonged), maternal conditions complicating pregnancy/delivery, fetal conditions complicating pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in clinical trial)]
J0151 — Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
J0401 — Injection, aripiprazole (abilify maintena), 1 mg
J0717 — Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1442 — Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
J1446 — Injection, tbo-filgrastim, 5 micrograms
J1556 — Injection, immune globulin (bivigam), 500 mg
J1602 — Injection, golimumab, 1 mg, for intravenous use
J3060 — Injection, taliglucerase alfa, 10 units
J3489 — Injection, zoledronic acid, 1 mg
J7301 — Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
J7316 — Injection, ocriplasmin, 0.125 mg
J7508 — Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
J9047 — Injection, carfilzomib, 1 mg
J9262 — Injection, omacetaxine mepesuccinate, 0.01 mg
J9306 — Injection, pertuzumab, 1 mg
J9354 — Injection, ado-trastuzumab emtansine, 1 mg
J9371 — Injection, vincristine sulfate liposome, 1 mg
J9400 — Injection, ziv-aflibercept, 1 mg
L0455 — Tlso, flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf
L0457 — Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated, off-the-shelf
L0467 — Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf
L0469 — Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf
L0641 — Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
L0642 — Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
L0643 — Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
L0648 — Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
L0649 — Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
L0650 — Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
L0651 — Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf
L1812 — Knee orthosis, elastic with joints, prefabricated, off-the-shelf
L1833 — Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf
L1848 — Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated, off-the-shelf
L3678 — Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated, off-the-shelf
L3809 — Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type
L3916 — Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelf
L3918 — Hand orthosis, metacarpal fracture orthosis, prefabricated, off-the-shelf
L3924 — Hand finger orthosis, without joints, may include soft interface, straps, prefabricated, off-the-shelf
L3930 — Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, off-the-shelf
L4361 — Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf
L4387 — Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf
L4397 — Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated, off-the-shelf
L5969 — Addition, endoskeletal ankle-foot or ankle system, power assist, includes any type motor(s)
L8679 — Implantable neurostimulator, pulse generator, any type
Q0161 — Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q2028 — Injection, sculptra, 0.5 mg
Q3027 — Injection, interferon beta-1a, 1 mcg for intramuscular use
Q3028 — Injection, interferon beta-1a, 1 mcg for subcutaneous use
Q4137 — Amnioexcel, amnioexcel plus or biodexcel, per square centimeter (add-on, list separately in addition to primary procedure)
Q4138 — Biodfence dryflex, per square centimeter (add-on, list separately in addition to primary procedure)
Q4139 — Amniomatrix or biodmatrix, injectable, 1 cc
Q4140 — Biodfence, per square centimeter (add-on, list separately in addition to primary procedure)
Q4141 — Alloskin ac, per square centimeter (add-on, list separately in addition to primary procedure)
Q4142 — Xcm biologic tissue matrix, per square centimeter (add-on, list separately in addition to primary procedure)
Q4143 — Repriza, per square centimeter (add-on, list separately in addition to primary procedure)
Q4145 — Epifix, injectable, 1 mg
Q4146 — Tensix, per square centimeter (add-on, list separately in addition to primary procedure)
Q4147 — Architect, architect px, or architect fx, extracellular matrix, per square centimeter (add-on, list separately in addition to primary procedure)
Q4148 — Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter (add-on, list separately in addition to primary procedure)
Q4149 — Excellagen, 0.1 cc
S9960 — Ambulance service, conventional air service, nonemergency transport, one way (fixed wing)
S9961 — Ambulance service, conventional air service, nonemergency transport, one way (rotary wing)
T4544 — Adult sized disposable incontinence product, protective underwear/pull-on, above extra large, each

Added effective April 1, 2014 (5)

C9021 — Injection, obinutuzumab, 10 mg
C9739 — Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants
C9740 — Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants
G0471 — Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)
Q2052 — Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)

Added effective June 2, 2014 (1)

G0472 — Hepatitis c antibody screening, for individual at high risk and other covered indication(s)

Added effective July 1, 2014 (12)

C2644 — Brachytherapy source, cesium-131 chloride solution, per millicurie
C9022 — Injection, elosulfase alfa, 1mg
C9134 — Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
Q9970 — Injection, ferric carboxymaltose, 1mg
Q9972 — Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
Q9973 — Injection, epoetin beta, 1 microgram, (non-esrd use)
Q9974 — Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
S0144 — Injection, propofol, 10 mg
S1034 — Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices
S1035 — Sensor; invasive (e.g., subcutaneous), disposable, for use with artificial pancreas device system
S1036 — Transmitter; external, for use with artificial pancreas device system
S1037 — Receiver (monitor); external, for use with artificial pancreas device system

Deleted effective July 1, 2014 (1)

C9441 — Injection, ferric carboxymaltose, 1 mg

Added effective October 1, 2014 (13)

C9023 — Injection, testosterone undecanoate, 1 mg
C9025 — Injection, ramucirumab, 5 mg
C9026 — Injection, vedolizumab, 1 mg
C9135 — Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
C9741 — Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report
G0466 — Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit
G0467 — Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit
G0468 — Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv
G0469 — Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit
G0470 — Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit
K0901 — Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf
K0902 — Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf
S8032 — Low-dose computed tomography for lung cancer screening

Added effective October 9, 2014 (1)

G0464 — Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)

Source: CMS HCPCS Level II alpha-numeric file (add and termination dates).

Source data

Source organization: CMS
Source release: HCPCS Level II October 2026 alpha-numeric file
Source file: october-2026-alpha-numeric-hcpcs-file.zip
File checksum (SHA-256): c25240c63108756d4ba6c0ea785c517117d83bfed9526c51da8acf123de1feb6
Data read date: Data not available in the current MedCoder release record.
Effective date: CMS effective dates within 2014
Release type: Quarterly (January, April, July, October), with occasional mid-quarter additions
Methodology: Each code's add date and termination date are read from the alpha-numeric file. A deletion is dated the first day the code is no longer valid, the day after its termination date. Description revisions are not recorded as changes.

These changes are based on recorded release data. MedCoder does not generate coding changes with AI.

All releases in the Change Ledger